On the public citation graph
HER 2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks
0 signed · 41 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ijc.29210openalex-snapshot
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
inferredcites →https://doi.org/10.1007/s00428-010-0952-2openalex-snapshot
HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
inferredcites →https://doi.org/10.1007/s10120-014-0453-0openalex-snapshot
HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance
inferredcites →https://doi.org/10.1007/s11912-015-0493-6openalex-snapshot
Advances in the Management of Gastric and Gastroesophageal Cancers
inferredcites →https://doi.org/10.1007/s12013-011-9286-1openalex-snapshot
Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens
inferredcites →https://doi.org/10.1016/j.giec.2008.05.003openalex-snapshot
Gastric Cancer: Pathogenesis, Screening, and Treatment
inferredcites →https://doi.org/10.1016/j.humpath.2013.12.010openalex-snapshot
Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status
inferredcites →https://doi.org/10.1016/j.humpath.2015.02.011openalex-snapshot
Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks
inferredcites →https://doi.org/10.1016/s0140-6736(10)61121-xopenalex-snapshot
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
inferredcites →https://doi.org/10.1038/modpathol.2011.198openalex-snapshot
HER2 testing in gastric cancer: a practical approach
inferredcites →https://doi.org/10.1038/modpathol.2012.147openalex-snapshot
HER-2 intratumoral heterogeneity
inferredcites →https://doi.org/10.1038/modpathol.2012.205openalex-snapshot
Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas
inferredcites →https://doi.org/10.1038/modpathol.2012.36openalex-snapshot
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
inferredcites →https://doi.org/10.1093/annonc/mdi064openalex-snapshot
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
inferredcites →https://doi.org/10.1093/annonc/mds528openalex-snapshot
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
inferredcites →https://doi.org/10.1097/pdm.0b013e31816f6374openalex-snapshot
Bright-field In Situ Hybridization for HER2 Gene Amplification in Breast Cancer Using Tissue Microarrays
inferredcites →https://doi.org/10.1111/ajco.12263openalex-snapshot
Human epidermal growth factor receptor 2 testing in gastric cancer: Recommendations of an A sia‐ P acific T ask F orce
inferredcites →https://doi.org/10.1111/apm.1965.64.1.31openalex-snapshot
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMA
inferredcites →https://doi.org/10.1111/j.1365-2559.2008.03028.xopenalex-snapshot
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
inferredcites →https://doi.org/10.1159/000288295openalex-snapshot
Targeted HER2 Treatment in Advanced Gastric Cancer
inferredcites →https://doi.org/10.1200/jco.2009.27.15_suppl.520openalex-snapshot
Benefit of adjuvant trastuzumab in breast cancer patients with focal HER2 amplified clones: Data from N9831 Intergroup Adjuvant Trial
inferredcites →https://doi.org/10.1245/s10434-012-2818-0openalex-snapshot
A Large Cohort of Consecutive Patients Confirmed Frequent HER2 Positivity in Gastric Carcinomas with Advanced Stages
inferredcites →https://doi.org/10.1309/ajcp51hcgpopwscyopenalex-snapshot
Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab
inferredcites →https://doi.org/10.18632/oncotarget.5368openalex-snapshot
Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens
inferredcites →https://doi.org/10.3892/or.2015.4528openalex-snapshot
Targeted therapy for gastric cancer: Current status and future directions (Review)
inferredcites →https://doi.org/10.5858/arpa.2013-0604-oaopenalex-snapshot
HER2/neu Testing in Gastric Cancer by Immunohistochemistry: Assessment of Interlaboratory Variation
inferredcites →https://doi.org/10.5858/arpa.2016-0331-cpopenalex-snapshot
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
inferredcites →https://doi.org/10.7326/0003-4819-70-1-248_1openalex-snapshot
TNM Classification of Malignant Tumours.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4667606openalex-extracted
Prediction of the Optimal Number of Tumor Blocks for Her2 Assessment in Gastric Carcinoma Resection Specimens: From Clinical Data to Mathematical Model Simulations
inferred← citeshttps://doi.org/10.1007/s10147-026-03118-8openalex-snapshot
Intratumoral heterogeneity of intermediate CLDN18.2 expression in gastric cancer
inferred← citeshttps://doi.org/10.1016/j.cllc.2025.11.015openalex-snapshot
A Comprehensive Analysis of HER2 status Heterogeneity Using Matched Samples among Potential Beneficiaries of Trastuzumab Deruxtecan Therapy in Non-Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1016/j.prp.2020.152882openalex-snapshot
The age variation of HER2 immunohistochemistry positive rate in biopsy specimens of gastric cancer
inferred← citeshttps://doi.org/10.1016/j.prp.2020.153229openalex-snapshot
Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer
inferred← citeshttps://doi.org/10.1080/14737140.2018.1510324openalex-snapshot
Current and future therapies for targeting HER2 mutations in gastrointestinal cancer
inferred← citeshttps://doi.org/10.1097/cco.0000000000000544openalex-snapshot
Human epidermal growth factor receptor 2-positive digestive tumors
inferred← citeshttps://doi.org/10.1097/pai.0000000000001085openalex-snapshot
Comparison of 22C3-PD-L1 Expression Between Paired Tumor Paraffin Blocks of Surgical Resection Specimens of Nonsmall Cell Lung Cancer
inferred← citeshttps://doi.org/10.1186/s13000-022-01230-7openalex-snapshot
Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China
inferred← citeshttps://doi.org/10.18632/aging.102415openalex-snapshot
Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.